Sarah Coutts
Intellectual Property Product Leader
-
United Kingdom
Intellectual property provides companies with a competitive advantage. It is a differentiator, and companies that own IP can monetise it by licencing it, selling it, or using it to create new products and services. Before building and growing these revenue streams, the company must firstly protect its IP via patents, trade mark etc. Secondly, it must consider the risk of infringement and transfer that risk in order to protect its balance sheet.
Working with key Lloyd’s markets, Marsh’s specialist IP team has created Edison IP, an innovative insurance solution that bridges the gap where traditional policies might not provide sufficient protection for defending infringement claims or meet client needs in protecting the value of their IP.
Marsh’s Edison IP provides efficient access to a single layer of up to USD85 million of primary or excess capacity (subject to underwriting), with an optional primary reinstatement, led by the leading IP insurers in the London market.
Developed exclusively for Marsh clients, Edison IP is available globally and provides the following benefits:
The scale of companies’ IP is growing, and IP infringement can profoundly affect businesses, industries, and economies. Disputes over the ownership or scope of IP are frequent, with economic turbulence causing companies to act more swiftly to protect their IP. In addition, claims activity from non-practicing entities is increasing, often bolstered by litigation funders willing to assume the risk and expense of litigating these disputes. And so now, more than ever, companies should recognise the importance of valuing, managing, and protecting their IP.
* Limited appetite for risks domiciled in India, China, and New York State.
** Excluded industries include non-practising entities, patent assertion entities, patent trolls, patent pooling structures; creative works; cryptocurrency; non-fungible tokens (NFTs); thermal coal mining, thermal coal power production, oil sands, or Arctic energy exploration, or any related infrastructure to the latter. Insurers have a limited appetite for pharmaceutical risks with revenues over USD1 billion; automotive risks (connected/self-drive vehicles) with revenues over USD500 million; semiconductor/chip manufacturers with revenues over USD500 million.
Watch our latest webinar on understanding intellectual property litigation risk.
Intellectual Property Product Leader
United Kingdom
Intellectual Property Practice Leader
United Kingdom